208 related articles for article (PubMed ID: 30758939)
1. Molecularly Imprinted Polymer Nanoparticles as Potential Synthetic Antibodies for Immunoprotection against HIV.
Xu J; Merlier F; Avalle B; Vieillard V; Debré P; Haupt K; Tse Sum Bui B
ACS Appl Mater Interfaces; 2019 Mar; 11(10):9824-9831. PubMed ID: 30758939
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
[TBL] [Abstract][Full Text] [Related]
3. A single amino-acid change in a highly conserved motif of gp41 elicits HIV-1 neutralization and protects against CD4 depletion.
Petitdemange C; Achour A; Dispinseri S; Malet I; Sennepin A; Ho Tsong Fang R; Crouzet J; Marcelin AG; Calvez V; Scarlatti G; Debré P; Vieillard V
Clin Infect Dis; 2013 Sep; 57(5):745-55. PubMed ID: 23696512
[TBL] [Abstract][Full Text] [Related]
4. Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1.
Gohain N; Tolbert WD; Acharya P; Yu L; Liu T; Zhao P; Orlandi C; Visciano ML; Kamin-Lewis R; Sajadi MM; Martin L; Robinson JE; Kwong PD; DeVico AL; Ray K; Lewis GK; Pazgier M
J Virol; 2015 Sep; 89(17):8840-54. PubMed ID: 26085162
[TBL] [Abstract][Full Text] [Related]
5. Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection.
Vieillard V; Costagliola D; Simon A; Debré P;
AIDS; 2006 Sep; 20(14):1795-804. PubMed ID: 16954720
[TBL] [Abstract][Full Text] [Related]
6. Sensing HIV related protein using epitope imprinted hydrophilic polymer coated quartz crystal microbalance.
Lu CH; Zhang Y; Tang SF; Fang ZB; Yang HH; Chen X; Chen GN
Biosens Bioelectron; 2012 Jan; 31(1):439-44. PubMed ID: 22143073
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status.
Lucar O; Su B; Potard V; Samri A; Autran B; Moog C; Debré P; Vieillard V
EBioMedicine; 2017 Aug; 22():122-132. PubMed ID: 28712768
[TBL] [Abstract][Full Text] [Related]
8. Preparation of an epitope-imprinted polymer with antibody-like selectivity for beta2-microglobulin and application in serum sample analysis with a facile method of on-line solid-phase extraction coupling with high performance liquid chromatography.
Yang F; Deng D; Dong X; Lin S
J Chromatogr A; 2017 Apr; 1494():18-26. PubMed ID: 28336138
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 neutralizing antibodies elicited by the candidate CBD1 epitope vaccine react with the conserved caveolin-1 binding motif of viral glycoprotein gp41.
Rey-Cuillé MA; Svab J; Benferhat R; Krust B; Briand JP; Muller S; Hovanessian AG
J Pharm Pharmacol; 2006 Jun; 58(6):759-67. PubMed ID: 16734977
[TBL] [Abstract][Full Text] [Related]
10. Guide to the Preparation of Molecularly Imprinted Polymer Nanoparticles for Protein Recognition by Solid-Phase Synthesis.
Xu J; Medina-Rangel PX; Haupt K; Tse Sum Bui B
Methods Enzymol; 2017; 590():115-141. PubMed ID: 28411635
[TBL] [Abstract][Full Text] [Related]
11. [Towards a vaccine for HIV infection: role of the gp41 envelope protein].
Debre P; Costagliola D; Legrand R; Vieillard V
Bull Acad Natl Med; 2009 Jan; 193(1):127-36; discussion 137-8. PubMed ID: 19718985
[TBL] [Abstract][Full Text] [Related]
12. Peptide imprinted polymer nanoparticles: a plastic antibody.
Hoshino Y; Kodama T; Okahata Y; Shea KJ
J Am Chem Soc; 2008 Nov; 130(46):15242-3. PubMed ID: 18942788
[TBL] [Abstract][Full Text] [Related]
13. Silicon nanoparticles coated with an epitope-imprinted polymer for fluorometric determination of cytochrome c.
Zhang XM; Qin YP; Ye HL; Ma XT; He XW; Li WY; Zhang YK
Mikrochim Acta; 2018 Feb; 185(3):173. PubMed ID: 29594524
[TBL] [Abstract][Full Text] [Related]
14. Epitope approach in molecular imprinting of antibodies.
Moczko E; Guerreiro A; Cáceres C; Piletska E; Sellergren B; Piletsky SA
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1124():1-6. PubMed ID: 31176265
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a conserved T cell epitope in HIV-1 gp41 recognized by vaccine-induced human cytolytic T cells.
Hammond SA; Obah E; Stanhope P; Monell CR; Strand M; Robbins FM; Bias WB; Karr RW; Koenig S; Siliciano RF
J Immunol; 1991 Mar; 146(5):1470-7. PubMed ID: 1704395
[TBL] [Abstract][Full Text] [Related]
16. Toward a Universal Method for Preparing Molecularly Imprinted Polymer Nanoparticles with Antibody-like Affinity for Proteins.
Xu J; Ambrosini S; Tamahkar E; Rossi C; Haupt K; Tse Sum Bui B
Biomacromolecules; 2016 Jan; 17(1):345-53. PubMed ID: 26644006
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
[TBL] [Abstract][Full Text] [Related]
18. NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand.
Vieillard V; Strominger JL; Debré P
Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10981-6. PubMed ID: 16046540
[TBL] [Abstract][Full Text] [Related]
19. The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope.
Benferhat R; Martinon F; Krust B; Le Grand R; Hovanessian AG
Mol Immunol; 2009 Feb; 46(4):705-12. PubMed ID: 19010547
[TBL] [Abstract][Full Text] [Related]
20. Molecularly Imprinted Polymers as Synthetic Antibodies for Protein Recognition: The Next Generation.
Tse Sum Bui B; Mier A; Haupt K
Small; 2023 Mar; 19(13):e2206453. PubMed ID: 36650929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
